Enhanced systemic T-cell activation after in situ gene therapy with radiotherapy in prostate cancer patients.
Enhanced systemic T-cell activation after in situ gene therapy with radiotherapy in prostate cancer patients. Int J Radiat Oncol Biol Phys. 2004 Jun 01; 59(2):562-71.